China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China

Written by Emily J. Thompson, Senior Investment Analyst

Source: businesswire

Updated: Dec 04 2023

0mins

Source: businesswire

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.